Neurotoxicity occurs when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system in such a way as to cause damage to nervous tissue. This can eventually disrupt or even kill neurons, key cells that transmit and process signals in the brain and other parts of the nervous system. Neurotoxicity can result from exposure to substances used in chemotherapy, radiation treatment, drug therapies, certain drug abuse, and organ transplants, as well as exposure to heavy metals, certain foods and food additives, pesticides, industrial and/or cleaning solvents, cosmetics, and some naturally occurring substances. Symptoms may appear immediately after exposure or be delayed. They may include limb weakness or numbness, loss of memory, vision, and/or intellect, uncontrollable obsessive and/or compulsive behaviors, delusions, headache, cognitive and behavioral problems and sexual dysfunction. Individuals with certain disorders may be especially vulnerable to neurotoxins.
The name implies the role of a neurotoxin although the term 'neurotoxic' may be used more loosely to describe states that are known to cause physical brain damage but where no obvious neurotoxin has been identified.
The term neurotoxic is used to describe a substance, condition or state that damages the nervous system and/or brain, usually by killing neurons. The term is generally used to describe a condition or substance that has been shown to result in observable physical damage. The presence of neurocognitive deficits alone is not usually considered sufficient evidence of neurotoxicity, as many substances exist which may impair neurocognitive performance without resulting in the death of neurons. This may be due to the direct action of the substance, with the impairment and neurocognitive deficits being temporary, and resolving when the substance is metabolised from the body. In some cases the level or exposure-time may be critical, with some substances only becoming neurotoxic in certain doses or time periods. Some of the most common naturally occurring brain toxins that lead to neurotoxicity as a result of excessive dosage are: Beta amyloid (Aβ), Glutamate and Oxygen radicals. When present in high concentrations they can lead to neurotoxicity and death (apoptosis). Some of the symptoms that result from cell death include: loss of motor control, cognitive deterioration and autonomic nervous system dysfunction. Additionally, neurotoxicity has been found to be a major cause of neurodegenerative diseases such as Alzheimer’s disease (AD).
Aβ was found to cause neurotoxicity and cell death in the brain when found in high concentrations. Aβ results from a mutation that occurs when protein chains are cut at wrong locations, resulting in chains of different length that are unusable. Thus they are left in the brain until they are broken down, but meanwhile if enough accumulate, they form plaques which are regarded toxic to neurons. Aβ uses several routes in the CNS to cause cell death. An example is through the nicotinic acetylcholine receptor (nAchRs), which is a receptor commonly found along the surfaces of the cells that respond to nicotine stimulation, turning them on or off. Aβ was found manipulating the level of nicotine in the brain along with the MAP kinase, another signaling receptor, to cause cell death. Another chemical in the brain that Aβ regulates is JNK; this chemical halts the extracellular signal-regulated kinases (ERK) pathway, which normally functions as memory control in the brain. As a result this memory favoring pathway is stopped and the brain loses essential memory function. The loss of memory is a symptom of neurodegenerative disease, including AD. Another way Aβ cause cell death is through the phosphorylation of AKT, this occurs as the element phosphate is bound to several sites on the protein. This phosphorylation allows AKT to interact with BAD, a protein known to cause cell death. Thus an increase in Aβ results in an increase of the AKt/BAD complex, in turn stopping the action of the anti-apoptotic protein Bcl-2, which normally functions to stop cell death, causing accelerated neuron breakdown and the progression of AD.
Glutamate is a chemical found in the brain that poses a toxic threat to neurons when found in high concentrations. This concentration equilibrium is highly sensitive, and it’s usually found in millimolar amounts in the brain. When disturbed, an accumulation of glutamate occurs as a result of a mutation in the glutamate transporters, which act like pumps to drain glutamate from the brain. Naturally, glutamate concentration is several times higher in the blood than in the brain; in turn the body must act to maintain equilibrium between the two concentrations by pumping the glutamate out of the bloodstream and into the brain and vice versa. In the event of a mutation, the glutamate transporters are unable to pump back the glutamate into the blood; thus a higher concentration accumulates in the brain. When released it acts on several receptors that translate its release into an increase in calcium production. Glutamate results in cell death by turning on the N-methyl-D-aspartic acid receptors (NMDA); this receptor causes an increased release of calcium ions (Ca2+) into the cell. As a result, the increased concentration of Ca2+ directly increases the stress on mitochondria, resulting in excessive oxidative phosphorylation and production of Reactive Oxygen Species (ROS) via the activation of nitric oxide synthase, ultimately leading to cell death. Aβ was also found aiding this route to neurotoxicity by enhancing neuron vulnerability to glutamate.
The formation of oxygen radicals in the brain is achieved through the nitric oxide synthase (NOS) pathway. This reaction occurs as a response to an increase in the Ca2+ concentration inside a brain cell. This interaction between the Ca2+ and NOS results in the formation of the cofactor tetrahydrobiopterin (BH4), which then moves from the plasma membrane into the cytoplasm. As a final step, NOS is dephosphorylated yielding nitric oxide (NO), which accumulates in the brain, increasing its oxidative stress. There are several ROS including: superoxide, hydrogen peroxide and hydroxyl, all of which lead to neurotoxicity. Naturally, the body utilizes a defensive mechanism to diminish the fatal effects of the reactive species by employing certain enzymes to breakdown the ROS into small, benign molecules of simple oxygen and water. However, this breakdown of the ROS is not completely efficient; some reactive residues are left in the brain to accumulate, contributing to neurotoxicity and cell death. The brain is more vulnerable to oxidative stress, in comparison to other organs, due to its low oxidative capacity. Because neurons are characterized as postmitotic cells, meaning that they live with accumulated damage over the years, accumulation of ROS is fatal. Thus, increased levels of ROS age neurons, which leads to accelerated neurodegenerative processes and ultimately the advancement of AD.
The prognosis depends upon the length and degree of exposure and the severity of neurological injury. In some instances, exposure to neurotoxins can be fatal. In others, patients may survive but not fully recover. In other situations, many individuals recover completely after treatment.
- Multiple chemical sensitivity
- Neurotoxic drugs
- Penitrem A
- Akaike, A; Izume, Y; Kume, T, et al. “Mechanisms of Neuroprotective Effects of Nicotine and Acetylcholinesterase Inhibitors: Role of α4 and α7 Receptors in Neuroprotection” Journal of Molecular Neuroscience 40.1-2. (2009): 211-216.
- Brown, L; Buckingham, S; Jones, A, et al. “Nicotinic Acetylcholine Receptor Signaling: Roles in Alzheimer’s Disease and Amyloid Neuroprotection” Pharmacological Review 61.1. (2009): 39-61.
- Burkle, A; Huber, A; Stuchbury, G, et al. “Neuroprotective Therapies for Alzheimer’s Disease” Current Pharmacutical Design 12.6. (2006): 705-717.
- Kume, T; Izume, Y; Takada-Takatori, et al. “Roles of Nicotinic Receptors in Acetylcholinestrase Inhibitor-Induced Neuroprotection and Nicotinic Receptor Up-Regulation” Biological & Pharmaceutical Bulletin 32.3. (2009): 318-324.
- Kume, T; Sugimoto, M; Takada-Takatori, et al. “Acetylcholinesterase Inhibitors Used in Treatment of Alzheimer’s Disease Prevent Glutamate Neurotoxicity via Nicotinic Acetylcholine Receptors and Phospha tidylinositol 3-kinase Cascade” Neuropharmacology 51.3. (2006): 474-486.
- Shimohama, S. “Nicotinic Receptor Mediated Neuroprotection in Neurodegenerative Disease Models” Biological & Pharmaceutical Bulletin 32.3. (2009): 332-336.
Animal Poisons & Venoms: Batrachotoxin • Bestoxin • Birtoxin • Bungarotoxin • Charybdotoxin • Conotoxin • Saxitoxin • TetrodotoxinNeurotoxic drugs: Amphetamine • Lisdexamfetamine • Methamphetamine • αET • αMT • MBDB • MDA • MDEA • MDMA (Ecstasy) • PBA • PCA • PIA • 1,4-BD • GBL • GHB • Ibotenic Acid • Dizocilpine (MK-801) • Ketamine • Phencyclidine (PCP) • 5,7-DHT • 6-OHDA • MPTP/MPP+ • Norsalsolinol • Ethanol (Alcohol)
Bacterial toxins: Botulinum toxin • Tetanospasmin
Fungal toxins: Bicuculline
Plant toxins: Penitrem A • Picrotoxin
Nerve agents: Cyclosarin EA-3148 • GV (nerve agent) • Novichok agent • Sarin • Soman • Tabun (nerve agent) • VE (nerve agent) • VG (nerve agent) • VM (nerve agent) • VR (nerve agent) • VX (nerve agent)
Neurotransmitters and precursors: Dopamine • Glutamate • L-Tyrosine • L-Phenylalanine • L-DOPA (Levodopa) • L-Glutamine
Wikimedia Foundation. 2010.